Jerrold Sendrow
Director/Board Member bei VIRPAX PHARMACEUTICALS, INC.
Vermögen: 3 835 $ am 31.03.2024
Profil
Jerrold Sendrow is an Independent Director at Virpax Pharmaceuticals, Inc. since 2017.
Prior to this, he was a Director at SCILEX Pharmaceuticals, Inc. from 2014 to 2016.
He worked as an Accountant-Audit Departments at Peat Marwick Mitchell & Co. and as Head-Accountant at Touche Ross & Co. He also worked as an Accountant-Audit Departments at Touche Ross & Co. (Australia).
Mr. Sendrow completed his undergraduate degree from Adelphi University and Baruch College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.03.2024 | 900 ( 0,08% ) | 3 835 $ | 31.03.2024 |
Aktive Positionen von Jerrold Sendrow
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 01.01.2017 |
Ehemalige bekannte Positionen von Jerrold Sendrow
| Unternehmen | Position | Ende |
|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 01.11.2016 |
| Touche Ross & Co. | Comptroller/Controller/Auditor | - |
| Touche Ross & Co. (Australia) | Comptroller/Controller/Auditor | - |
| Peat Marwick Mitchell & Co. | Comptroller/Controller/Auditor | - |
Ausbildung von Jerrold Sendrow
| Adelphi University | Undergraduate Degree |
| Baruch College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
| Peat Marwick Mitchell & Co. | Commercial Services |
| Touche Ross & Co. | Commercial Services |
| Touche Ross & Co. (Australia) |
